Please login to the form below

Not currently logged in
Email:
Password:

Aerospan

This page shows the latest Aerospan news and features for those working in and with pharma, biotech and healthcare.

Mylan raises offer for Meda to $9bn

Mylan raises offer for Meda to $9bn

Also due to launch shortly is Aerospan (flunisolide), an inhaler therapy for asthma - incorporating a spacer to improve drug delivery to the lungs - that Meda has said could achieve sales of

Latest news

  • Meda buys US respiratory firm Acton in $200m deal Meda buys US respiratory firm Acton in $200m deal

    Meda buys US respiratory firm Acton in $200m deal. Swedish pharma firm gains access to asthma treatment Aerospan. ... Meda is paying $125m upfront for Acton, which has been sitting on a US approval for an inhaled corticosteroid product called Aerospan

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics